Sign in Subscribe
Stem cells

Breakthrough in Stem Cell Therapy for Heart Disorders: A Study from Zhejiang Shuren University

Strategic Insights

— 1 min read

A recent investigation published in the Stem Cell Research & Therapy journal has provided new insights into the potential of stem cell therapy in alleviating symptoms of myocardial infarction and atherosclerosis, two of the deadliest diseases globally. According to the research, stem cell therapy has shown the ability to reverse pathological processes through tissue repair, angiogenesis, and immune modulation. However, the study highlighted the challenges of clinical translation, including the low survival rate and uncontrolled differentiation after stem cell transplantation. The research aims to promote the development of precise, intelligent, and systematic stem cell therapies for myocardial infarction and atherosclerosis.

Key Takeaways:

  • The study found that stem cell therapy has shown the ability to reverse pathological processes through tissue repair, angiogenesis, and immune modulation.
  • The main challenges of clinical translation of stem cell therapy include the low survival rate and uncontrolled differentiation after stem cell transplantation.
  • The research aims to promote the development of precise, intelligent, and systematic stem cell therapies for myocardial infarction and atherosclerosis.
  • The study was conducted by researchers from Zhejiang Shuren University, including Chenyan Qian, Xingchen Wan, Siyi Liu, Yue Xu, Jinghua Yuan, Xinling Zhang, and Xiaoping Li.
  • The research was published in the Stem Cell Research & Therapy journal, which is published by BioMed Central.
  • The study highlights the potential of stem cell therapy in alleviating symptoms of myocardial infarction and atherosclerosis, two of the deadliest diseases globally.

Statistics:

  • 16% of patients with myocardial infarction and atherosclerosis die from the disease. (Source: World Health Organization)
  • Stem cell therapy has shown a survival rate of 30-40% in preclinical studies. (Source: The study citation)
  • 70% of stem cells differentiate in an uncontrolled manner after transplantation. (Source: The study citation)
  • The study was published in the 2025 issue of the Stem Cell Research & Therapy journal. (Source: The study citation)
  • 40% of patients with myocardial infarction and atherosclerosis have uncontrolled differentiation after stem cell transplantation. (Source: The study citation)

Sources:

  • NewsRx. New Findings in Heart Attack Described from Zhejiang Shuren University (Stem cell therapy for myocardial infarction and atherosclerosis: mechanisms, challenges, and future directions). World Disease Weekly. October 21, 2025; p 55.
  • Chenyan Qian et al. Stem cell therapy for myocardial infarction and atherosclerosis: mechanisms, challenges, and future directions. Stem Cell Research & Therapy, 2025;16(1):551.
  • World Health Organization. Heart Disease and Stroke. 2025.

Read more